// App-Quantinova.ai

P408 : Faecal infliximab and disease activity in Acute Severe Ulcerative Colitis

Researchers

Presenter

  • Shields, S

Principal Investigators

  • Dunlop, A

  • Gerasimidis, K

  • Nichols, B

  • Galloway, P

  • Macdonald, J

  • Hansen, R

  • Seenan, J.P

Medical Centers

  • Queen Elizabeth University Hospital, Glasgow, United Kingdom

  • Queen Elizabeth University Hospital, Glasgow, United Kingdom

  • University of Glasgow, School of Medicine- Dentistry and Nursing, Glasgow, United Kingdom

  • Royal Hospital for Children, Gastroenterology, Glasgow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • C reactive protein

  • Faecal calprotectin

Drug/Treatment

  • Infliximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved